Veterinarians can now order UpCard®-CA1 (torsemide oral solution) through their preferred distributor or Vetoquinol Territory Manager. For full prescribing information, visit http://www.vetoquinolusa.com/upcard-ca1-info
UpCard-CA1 is conditionally approved by the FDA for use with concurrent therapy with pimobendan, spironolactone, and an angiotensin converting enzyme (ACE) inhibitor for the management of pulmonary edema in dogs with congestive heart failure caused by myxomatous mitral valve disease (MMVD).
We're in New Orleans this week for the 2024 National Business Meeting!
MAKING HISTORY! 🎉🎉🎉
Our dedication to sustainability, both in the present and for the future. 🌎
Last chance to enter the #VetTechsInAction giveaway! Enter before Oct. 30 to win at https://bit.ly/3sZuLwe. Congratulations to this week’s winner, Deneige! She uses treats like this ‘pupcake’ to avoid restraints and make veterinary appointments minimally stressful! #fearfree #VetTechWeek
Growth driven by innovation! #vetoquinol90 #vetoquinol
Vetoquinol, a success story! 90 years in animal health, and a future to build together.
#vetoquinol90
#vetoquinol
For the last 90 years, our unique history has been written with the esteemed contribution of more than 2,500 team members worldwide. Get a glimpse into what has helped Vetoquinol thrive and rank among the top in the animal health industry.
https://vetoquinol.com/en
#vetoquinol
#vetoquinolusa
#vetoquinol90
To celebrate Vetoquinol’s 90th anniversary, we are telling our story in a series of video clips highlighting key milestones that have marked the last nine decades.
These highlights feature our long-standing experience in the animal health industry, and our vision for the future while showcasing Vetoquinol growth through the eras. These clips also create the opportunity to emphasize the contribution of the men and women who have been part of the company’s workforce over the past 90 years.
Enjoy!
#vetoquinol90
#vetoquinol
#vetoquinolusa
90 years in animal health, a future to build together. Celebrate with us! 💚
www.vetoquinol.com
#vetoquinol90
No crushing or flushing required. Clevor® (ropinirole ophthalmic solution) is ready when you need it. CLEVOR® is indicated for the induction of vomiting in dogs.
IMPORTANT SAFETY INFORMATION: Do not use in dogs with central nervous system depression or seizures. Do not use in cases of ingestion of sharp foreign objects, corrosive agents (acids or alkalis), volatile substances or organic solvents. CLEVOR® should not be administered in cases with corneal ulceration, ocular irritation, or ocular injury. Do not use when there is a known sensitivity to ropinirole or the inactive ingredients. ADVERSE REACTIONS MAY INCLUDE: Transient mild or moderate hyperemia of the eye, ocular discharge, protrusion of the 3rd eyelid and blepharospasm, transient mild lethargy and increased heart rate. Not recommended for use in breeding, pregnant or lactating dogs. CLEVOR® has not been evaluated in dogs with heart or liver impairments or dogs younger than 4.5 months or less than 4 pounds. Dopamine antagonists, neuroleptics and other medicines with antiemetic properties may reduce the effectiveness of ropinirole. CLEVOR® should be administered by a veterinary professional. Gloves and protective eyewear should be worn when administering. Not for use in humans. Keep out of reach of children.
For full prescribing information go to: https://www.vetoquinolusa.com/clevor-info.
Dogs eat it. You drop it. Dogs are waiting for their chance at the candy bowl. Be ready with Clevor® (ropinirole ophthalmic solution).
CLEVOR® is indicated for the induction of vomiting in dogs.
Learn more https://www.vetoquinolusa.com/clevor
IMPORTANT SAFETY INFORMATION: Do not use in dogs with central nervous system depression or seizures. Do not use in cases of ingestion of sharp foreign objects, corrosive agents (acids or alkalis), volatile substances or organic solvents. CLEVOR® should not be administered in cases with corneal ulceration, ocular irritation, or ocular injury. Do not use when there is a known sensitivity to ropinirole or the inactive ingredients. ADVERSE REACTIONS MAY INCLUDE: Transient mild or moderate hyperemia of the eye, ocular discharge, protrusion of the 3rd eyelid and blepharospasm, transient mild lethargy and increased heart rate. Not recommended for use in breeding, pregnant or lactating dogs. CLEVOR® has not been evaluated in dogs with heart or liver impairments or dogs younger than 4.5 months or less than 4 pounds. Dopamine antagonists, neuroleptics and other medicines with antiemetic properties may reduce the effectiveness of ropinirole. CLEVOR® should be administered by a veterinary professional. Gloves and protective eyewear should be worn when administering. Not for use in humans. Keep out of reach of children. For full prescribing information go to: https://www.vetoquinolusa.com/clevor-info.
Helping Pets Cope With Fireworks
